Investing Profile

Matthew De Silva

InvestorVCAngel
Venture Partner at Builders VC
builders.vcChicago, Illinois
Photo of Matthew De Silva, Venture Partner at Builders VC

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Cornell University Network
384 CONNECTIONS
BofA Securities Network
171 CONNECTIONS
Builders VC Network
15 CONNECTIONS
Clarium Capital Management Network
13 CONNECTIONS
cb
Builders VC Venture Partner
$100K - $5.0M
$1.5M
3
CompanyStageDateRound SizeTotal Raised
Eigen Therapeutics
SeedDec 2022$7M
$7M
Co-investors: Supachai Kid Parchariyanon (SeaX Ventures), Milad Alucozai (Entrepreneur First), Jano Búza (ZAKA VC), Supachai Kid Parchariyanon (HOF Capital)
Arpeggio Bio
Series ASep 2022$17M
$20M
Co-investors: Alice Zhang (Princeton University Investment Company), Milad Alucozai (Entrepreneur First), Amit Mehta (Builders VC)
Enveda Biosciences
Series AJun 2021$51M
$500M
Co-investors: Rohit Sharma (True Ventures), Zavain Dar (Dimension Capital), Pegah Ebrahimi (FPV Ventures), Pablo Lubroth (Enveda), Christian Scherrer (Kinnevik), Chris Gibson (6 Dimensions Capital), rajiv chegu (Serent Capital), Henry Kravis
Intern Moore Capital ManagementPresent
Analyst BofA SecuritiesPresent
Portfolio Manager Clarium Capital ManagementPresent
Advisor and Angel Investor ENDPOINT HEALTHPresent
Angel Investor & Syndicate Lead Longtail Health VenturesPresent
Chief Operating Officer PathosPresent
Founder and CEO NotablePresent
Founder & Executive Chairman NotablePresent
Venture Partner Builders VCPresent
Cornell University B.S. Applied Economics & Management
Sign in with Google →
Sign in with Google →